Fetal haemopoiesis marking low-grade urinary bladder cancer

British Journal of Cancer

Volumn 107, Issue 3, 2012, Pages 477-481

  Wolk, M ^a   Martin, J E ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

bladder cancer; fetal haemoglobin; fetal haemopoiesis; HbF

Indexed keywords

HEMOGLOBIN F;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CELL PROLIFERATION; CLINICAL ASSESSMENT; DISEASE SEVERITY; ERYTHROBLAST; ERYTHROCYTE; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSELS; CARCINOMA, TRANSITIONAL CELL; CELL TRANSFORMATION, NEOPLASTIC; ERYTHROBLASTS; ERYTHROCYTES; FETAL HEMOGLOBIN; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84864376503     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.268     Document Type: Article

References (25)

1. Bhnu NV, Trice TA, Lee YT, Miller JL (2004) A signaling mechanism for growth-related expression of fetal hemoglobin. Blood 103: 1929-1933
2. Carlson BM (1988) The development of the circulatory system. In Patten's Foundations of Embryology, Dolinger E, Maisel J (eds). pp 594. McGraw-Hill: New York
3. Fyrberg A, Peterson C, Kagedal B, Lotfi K (2011) Induction of fetal hemoglobin and ABCB1 gene exspression in 9-b-D-arabinofuranosylguanineresistant MOLT-4 cells. Cancer Chemother Pharmacol 68: 583-591
4. Gabbianelli M, Testa U, Morsilli O, Pelosi E, Saulle E, Petrucci E, Casteli G, Giovinazzi S, Mariani G, Fiori ME, Bonanno G, Massa A, Corce CM Fontana L, Peschele C (2010) Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex. Haematologica 95: 1253-1260
5. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK (2011) Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 9: 1071-1121
6. Hsu Sb, Raine L (1984) The use of avidin-biotin-peroxidase complex (ABC) in diagnostic and research pathology. In Advances in Immunochemistry, Delellis Ra (ed). pp 31-42. Mason: New York
7. Lavelle DE (2004) The molecular mechanism of fetal hemoglobin reactivation. Semin Hematol 41(4, suppl 6): 3-10
8. Manca L, Masala B (2008) Disorder of synthesis of human fetal hemoglobin. IUBMB Life 60: 94-111
9. Mukhtar S, Perry M JA (2011) Future prospects for bladder cancer biomarkers. Brit J Urol Int 108: 1336-1345
10. Miyake M, Sugano K, Sugino H, Imai K, Mutsumoto E, Maeda K, Fukozono S, Ichikawa H, Kawashima K, Hirabayashi K, KJodama T, Fujimoto H, Kakizoe T, Kanai Y, Fujimoto K, Hirao Y (2010) Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer. Cancer Sci 101: 250-258
11. Rautonen J, Mari AS (1990) Initial blood fetal hemoglobin concentration is elevated and is associated with prognosis in children with acute lymphoid or myeloid leukemia. Blut 61: 17-20
12. Sankaran VG (2011) Targeted therapeutic strategies for fetal hemoglobin induction. Heamatol Am Soc Heamatol Educ Program 2011: 459-465
13. Saunthararajah Y, Lavelle D, DeSimone J (2004) DNA hypo-methylation agents and sickle cell disease. Brit J Haematol 126: 629-636
14. Sheridan BL, Weatherhall DJ, Clegg JB, Prichard J, Wood WG, Challender ST, DUrrant IJ, McWhirter WR, Ali M, Partridge JW, Thompson EN (1976) The patterns of fetal haemoglobin production in leukaemia. Brit J Haematol 32: 487-506
15. Stoeber K, Swinn R, Prevost AT, de Clive-Lowe P, Halsall I, Dilworth SM, Marr J, Turner WH, Bullock N, Doble A, Hales CN, Williams GH (2002) Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst 94: 1071-1079
16. Wang R, Morris DS, Tonlis SA, Lonigro RJ, Tsodikov A, Mehra R, Giorando TJ, Kunjo LP, Lee CT, Weizer AZ, Chinaian AM (2009) Development of a multiplex quantitative PCR signature to predict progression in nonmuscle-invasive bladder cancer. Cancer Res 69: 3810-3818
17. Witt O, Monkemeyer S, Roenndahl G, Erdlenbruch B, Reinhardt D, Kanbach K, Pekrun A (2003) Induction of fetal hemogloboin expression by the histone deacetylase inhibitor ampicin. Blood 101: 2001-2007
18. Wojda U, Leigh KR, Njoroge JM, Jackson KA, Natarajan B, Stitely M, Miller JL (2003) Fetal hemoglobin modulation during human erythropoiesis: stem cell factor has "late" effects related to the expression pattern of CD117. Blood 101: 492-497
19. Wolk M, Kieselstein M (1983) Graded hemagglutination inhibition for quantification of human fetal hemoglobin. Clin Chem 29: 1372-1375
20. Wolk M, Kiesekstein M, Brufman G (1988) Evaluation of fetal hemoglobin in various malignancies with reference to the patients' age. Tumor Biol 9: 95-100
21. Wolk M, Kieselstein M, Ben-Dor CG, Brufman G (1991) Fetal Hemoglobin screening in whole blood and in plasma of cancer patients. Tumor Biol 12: 45-51
22. Wolk M, Newland AC, Dela Salle B, Peleg M, Brufman G (1999) Refinement of plasma fetal hemoglobin (HbF) measurements, as related to whole blood HbF, in cancer patients. J Tumor Marker Oncol 14: 115-124
23. Wolk M, Martin JE, Reinus C (2006) Development of fetal haemoglobin-blood cells (F cells) within colorectal tumour tissues. J Clin Pathol 59: 598-602
24. Wolk M, Martin JE, Nowicki M (2007) Foetal haemoglobin-blood cells (F-cells) as a feature of embryonic tumours (blastemas). Brit J Cancer 97: 412-419
25. Wu H-C, Huang C-T, Chang D-K (2008) Anti-angiogenic therapeutic drugs for treatment of human cancer. J Cancer Mol 4: 37-45